Terns Pharmaceuticals Appoints New CEO, Welcomes Four New Employees with Equity Awards
Terns Pharmaceuticals, Inc. has appointed a new CEO, with the announcement made on October 1, 2025. However, details about the new leader remain scarce, with no public news available.
On the same day, the company granted equity inducement awards to four new employees. The Compensation Committee of the Company's Board of Directors approved these awards.
The equity awards consist of options to purchase 118,000 shares of Terns common stock. These options have a 10-year term and an exercise price per share set at $7.81. The vesting schedule spans four years, contingent upon the employees' continued service with the company.
While the new CEO's identity remains unknown, Terns Pharmaceuticals, Inc. has welcomed four new employees with equity inducement awards. The company continues to grow and adapt, with these appointments signaling a commitment to attracting and retaining top talent.
Read also:
- Eric Dane Diagnosed with ALS, Advocates for ACT for ALS
- Deepwater Horizon Oil Spill: BP Faces Record-Breaking Settlement - Dubbed 'Largest Environmental Fine Ever Imposed'
- Meta Unveils Ray-Ban AR Display Sunglasses; TikTok Agrees to $200 Million Deal
- Historic downtown temples to receive restoration funds totaling over 25 million pesos
